200 related articles for article (PubMed ID: 18406868)
1. Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers.
Mangia A; Chiarappa P; Tommasi S; Chiriatti A; Petroni S; Schittulli F; Paradiso A
Cancer Genet Cytogenet; 2008 Apr; 182(2):75-83. PubMed ID: 18406868
[TBL] [Abstract][Full Text] [Related]
2. Distinct chromosomal aberrations of ampulla of Vater and pancreatic head cancers detected by laser capture microdissection and comparative genomic hybridization.
Chang MC; Chang YT; Tien YW; Sun CT; Wu MS; Lin JT
Oncol Rep; 2005 Oct; 14(4):867-72. PubMed ID: 16142344
[TBL] [Abstract][Full Text] [Related]
3. A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation.
Alvarez S; Diaz-Uriarte R; Osorio A; Barroso A; Melchor L; Paz MF; Honrado E; Rodríguez R; Urioste M; Valle L; Díez O; Cigudosa JC; Dopazo J; Esteller M; Benitez J
Clin Cancer Res; 2005 Feb; 11(3):1146-53. PubMed ID: 15709182
[TBL] [Abstract][Full Text] [Related]
4. Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours.
Peng DF; Sugihara H; Mukaisho K; Tsubosa Y; Hattori T
J Pathol; 2003 Nov; 201(3):439-50. PubMed ID: 14595756
[TBL] [Abstract][Full Text] [Related]
5. [Genetic screening of head-neck carcinomas using comparative genomic hybridization (CGH)].
Bockmühl U; Petersen I; Schwendel A; Dietel M
Laryngorhinootologie; 1996 Jul; 75(7):408-14. PubMed ID: 8924169
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors.
Hermsen MA; Baak JP; Meijer GA; Weiss JM; Walboomers JW; Snijders PJ; van Diest PJ
J Pathol; 1998 Dec; 186(4):356-62. PubMed ID: 10209483
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization.
Wilkens L; Bredt M; Flemming P; Kubicka S; Klempnauer J; Kreipe H
Am J Clin Pathol; 2000 Dec; 114(6):867-74. PubMed ID: 11338475
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.
De Angelis PM; Clausen OP; Schjølberg A; Stokke T
Br J Cancer; 1999 May; 80(3-4):526-35. PubMed ID: 10408863
[TBL] [Abstract][Full Text] [Related]
10. Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
Somiari SB; Shriver CD; He J; Parikh K; Jordan R; Hooke J; Hu H; Deyarmin B; Lubert S; Malicki L; Heckman C; Somiari RI
Cancer Genet Cytogenet; 2004 Dec; 155(2):108-18. PubMed ID: 15571796
[TBL] [Abstract][Full Text] [Related]
11. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
[TBL] [Abstract][Full Text] [Related]
12. CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12.
Maguire P; Holmberg K; Kost-Alimova M; Imreh S; Skoog L; Lindblom A
Int J Mol Med; 2005 Jul; 16(1):135-41. PubMed ID: 15942690
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization.
Aubele M; Mattis A; Zitzelsberger H; Walch A; Kremer M; Hutzler P; Höfler H; Werner M
Cancer Genet Cytogenet; 1999 Apr; 110(2):94-102. PubMed ID: 10214356
[TBL] [Abstract][Full Text] [Related]
14. [Cytogenetic aberrations of esthesioneuroblastoma studied by comparative genomic hybridization].
You XJ; Petersen I; Arps H; Draf W; Bockmühl U
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):16-21. PubMed ID: 15771791
[TBL] [Abstract][Full Text] [Related]
15. Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization.
Gronwald J; Jauch A; Cybulski C; Schoell B; Böhm-Steuer B; Lener M; Grabowska E; Górski B; Jakubowska A; Domagała W; Chosia M; Scott RJ; Lubiński J
Int J Cancer; 2005 Mar; 114(2):230-6. PubMed ID: 15540206
[TBL] [Abstract][Full Text] [Related]
16. Screening of genomic imbalances in glioblastoma multiforme using high-resolution comparative genomic hybridization.
Vranová V; Necesalová E; Kuglík P; Cejpek P; Pesáková M; Budínská E; Relichová J; Veselská R
Oncol Rep; 2007 Feb; 17(2):457-64. PubMed ID: 17203188
[TBL] [Abstract][Full Text] [Related]
17. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.
Tirkkonen M; Johannsson O; Agnarsson BA; Olsson H; Ingvarsson S; Karhu R; Tanner M; Isola J; Barkardottir RB; Borg A; Kallioniemi OP
Cancer Res; 1997 Apr; 57(7):1222-7. PubMed ID: 9102202
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.
van Beers EH; van Welsem T; Wessels LF; Li Y; Oldenburg RA; Devilee P; Cornelisse CJ; Verhoef S; Hogervorst FB; van't Veer LJ; Nederlof PM
Cancer Res; 2005 Feb; 65(3):822-7. PubMed ID: 15705879
[TBL] [Abstract][Full Text] [Related]
19. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
[TBL] [Abstract][Full Text] [Related]
20. Whole genome amplification for CGH analysis: Linker-adapter PCR as the method of choice for difficult and limited samples.
Pirker C; Raidl M; Steiner E; Elbling L; Holzmann K; Spiegl-Kreinecker S; Aubele M; Grasl-Kraupp B; Marosi C; Micksche M; Berger W
Cytometry A; 2004 Sep; 61(1):26-34. PubMed ID: 15351986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
